Surevest’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$3.8M Sell
23,262
-184
-0.8% -$31.1K 1.03% 29
2022
Q2
$4.16M Buy
23,446
+770
+3% +$137K 1.09% 24
2022
Q1
$4.02M Sell
22,676
-5,338
-19% -$908K 0.97% 36
2021
Q4
$4.79M Sell
28,014
-432
-2% -$70.7K 1.14% 38
2021
Q3
$4.59M Buy
28,446
+1,443
+5% +$246K 1.16% 39
2021
Q2
$4.45M Buy
27,003
+1,312
+5% +$217K 1.16% 42
2021
Q1
$4.22M Buy
25,691
+844
+3% +$137K 1.28% 46
2020
Q4
$3.91M Buy
24,847
+1,395
+6% +$206K 1.3% 41
2020
Q3
$3.49M Buy
23,452
+1,772
+8% +$262K 1.37% 32
2020
Q2
$3.05M Buy
21,680
+1,130
+5% +$165K 1.35% 36
2020
Q1
$2.69M Buy
20,550
+5,007
+32% +$710K 1.47% 16
2019
Q4
$2.27M Buy
15,543
+3,207
+26% +$435K 0.97% 33
2019
Q3
$1.6M Buy
12,336
+265
+2% +$34.9K 0.79% 55
2019
Q2
$1.68M Buy
12,071
+4,373
+57% +$605K 0.87% 38
2019
Q1
$1.08M Buy
7,698
+2,484
+48% +$333K 0.66% 43
2018
Q4
$673K Buy
+5,214
New +$727K 0.53% 48

Other funds holding JNJ

Surevest's JNJ Position: Q3 2022 in Review

Surevest reduced its Johnson & Johnson (JNJ) stake by 0.78% in Q3 2022, selling an estimated $31.1K and leaving 23,262 shares worth $3.8M. The position accounts for 1.03% of the portfolio, ranked #29.

Surevest first reported a position in JNJ in Q4 2018 and has held it in 16 quarters since. The position peaked at $4.79M in Q4 2021. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Surevest held 23,262 shares of Johnson & Johnson worth $3.8M as of Q3 2022.
  • Surevest sold 184 Johnson & Johnson shares in Q3 2022, an estimated $31.1K.
  • Johnson & Johnson made up 1.03% of Surevest's portfolio in Q3 2022, its #29 holding.
  • Surevest first reported a position in Johnson & Johnson in Q4 2018 and has held it in 16 quarters since.
  • Surevest's Johnson & Johnson position peaked at $4.79M in Q4 2021.
  • 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.